Showing results (91-100 of 122) with videos related to
Sort By:
Pageof 13
Heart (British Cardiac Society)|July 18, 2023
Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumoursGaspard Suc, Agnès Cachier, Olivia Hentic, et al.Endocrine-Related Cancer|September 16, 2025
Predictive value of metabolic state on PanNET response to mTOR inhibitorsJérôme Cros, Margot Bucau, Matthieu Tihy, et al.Endocrine Pathology|October 29, 2025
Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic TestingRuiqian Chen, Matthieu Tihy, Ludovic Lacroix, et al.Endocrine Pathology|November 3, 2025
Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating ChemotherapyLouis de Mestier, Thorvardur R Halfdanarson, Leonidas Apostolidis, et al.Neuroendocrinology|March 11, 2020
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?Elettra Merola, Wouter Zandee, Louis de Mestier, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2023
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN NetworkOphélie De Rycke, Marine Perrier, Éric Ouvrard, et al.Therapeutic Advances in Medical Oncology|November 20, 2024
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumorsPascal Hammel, Denis Smith, Pauline Afchain, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine TumorsEric Ouvrard, Louis De Mestier, Caroline Boursier, et al.Clinical Genetics|August 22, 2019
Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohortMathias Schwartz, Clement Korenbaum, Meriem Benfoda, et al.Journal of the National Cancer Institute|April 7, 2017
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic AdenocarcinomaAngélique Vienot, Guillaume Beinse, Christophe Louvet, et al.Pageof 13